Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Roger's 1998 Short Picks -- Ignore unavailable to you. Want to Upgrade?

To: Marconi who wrote (11596)	7/16/1998 1:50:00 PM
From: Franco Battista	Read Replies (1) \| Respond to of 18691

Hi Marconi, you can find the scrip results on the Zona thread for Mexico. Regardless of this, if Vasomax ever gets approved (and that is a big if) Viagra will already have been on the market for about two years and garnered much if not all the oral market. Vivus, which has a safer drug and was out before Viagra was literally crushed by the release of Viagra. So what do believe are the chances of Vasomax- a less effective, more dangerous, less known drug? And yes, I agree with Hank. This is a very highly manipulated stock. Not to be shorted with options or for the short term. If one gets on for the long haul it will be very profitable.